Shining a Light on How Early Tau-Related Brain Changes Affect Memory Loss
Principal Investigator
Martin Dahl, PhD
Max Planck Institute for Human Development (Germany)
Berlin, Germany
About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$199,130.46
Active Dates
July 01, 2024 - June 30, 2027
Grant ID
A2024006F
Mentor(s)
Ulman Lindenberger, PhD, Max Planck Institute for Human Development (Germany)
Goals
This project delves into the brainstem’s role in early tau accumulation and memory loss via advanced magnetic resonance imaging, plasma biomarkers, and long-term data, enhancing our understanding of Alzheimer’s progression.
Summary
This project spotlights previously understudied brain regions—tiny nuclei in the brainstem—that are the starting point of Alzheimer’s-related tau accumulation and investigates how their changes contribute to memory loss. Using innovative brain imaging techniques, blood-based biomarkers, and memory assessments collected over a decade from a large number of participants, this project improves our understanding of the time course of neural changes in later life and their mechanistic role in the earliest stages of Alzheimer’s development.
Unique and Innovative
The proposed project puts a spotlight on previously understudied brain regions that form the starting point of Alzheimer’s-related tau accumulation and how their changes contribute to memory loss. Using MRI, plasma biomarkers, and behavior densely sampled over a decade in large samples of participants, it advances our understanding of the temporal trajectory of late-life neural changes in the brainstem and their mechanistic role in the earliest stages of Alzheimer’s development.
Foreseeable Benefits
The proposed project closes an important gap in the literature by (1) estimating person-specific change in several brainstem structures and (2) determining how this relates to the buildup of disease biomarkers and hippocampal memory loss in older participants at risk for sporadic Alzheimer’s. Moreover, this project puts an emphasis on improving the reliability of MRI of the brainstem, which will help qualify these measures as imaging biomarkers for early-stage Alzheimer’s pathologic changes.
Related Grants
Alzheimer's Disease Research
Using Protein Signatures to Uncover Alzheimer's Disease Subtypes and Predict Disease Progression
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Saima Rathore, PhD
Current Organization
Emory University
Using Protein Signatures to Uncover Alzheimer's Disease Subtypes and Predict Disease Progression
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Saima Rathore, PhD
Current Organization
Emory University
Alzheimer's Disease Research
Clusterin Glycosylation for Early Detection of Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Qi Zhang, PhD
Current Organization
Emory University
Clusterin Glycosylation for Early Detection of Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Qi Zhang, PhD
Current Organization
Emory University
Alzheimer's Disease Research
How Biology and Blood Markers Shape Alzheimer’s Risk in Diverse Communities
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
María Carolina Dalmasso, PhD
Current Organization
Studies in Neuroscience and Complex Systems Unit
How Biology and Blood Markers Shape Alzheimer’s Risk in Diverse Communities
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
María Carolina Dalmasso, PhD
Current Organization
Studies in Neuroscience and Complex Systems Unit